These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 6712863)
1. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension. Zabludowski JR; Zoccali C; Isles CG; Murray GD; Robertson JI; Inglis GC; Fraser R; Ball SG Br J Clin Pharmacol; 1984 Mar; 17(3):309-16. PubMed ID: 6712863 [TBL] [Abstract][Full Text] [Related]
2. The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man. Zoccali C; Zabludowski JR; Isles CG; Murray GD; Inglis GC; Robertson JI; Fraser R; Ball SG Br J Clin Pharmacol; 1983 Sep; 16(3):305-11. PubMed ID: 6626423 [TBL] [Abstract][Full Text] [Related]
3. Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man. Fagard R; Cattaert A; Lijnen P; Staessen J; Vanhees L; Moerman E; Amery A Clin Sci (Lond); 1984 Jan; 66(1):17-25. PubMed ID: 6690191 [TBL] [Abstract][Full Text] [Related]
4. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278 [TBL] [Abstract][Full Text] [Related]
5. Ketanserin: a possible tool for studying the role of serotonin in hypertension. Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of ketanserin in conscious rabbits. Takata M; Zhang X; Sugimoto T; Ikeda K; Tomoda F; Mikawa M; Iida H; Mizumura Y Jpn Heart J; 1986 Jan; 27(1):95-106. PubMed ID: 2941601 [TBL] [Abstract][Full Text] [Related]
7. Ketanserin and alpha 1-adrenergic antagonism in humans. Zabludowski JR; Ball SG; Robertson JI J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S123-5. PubMed ID: 2412032 [TBL] [Abstract][Full Text] [Related]
9. Effects of ketanserin on cardiovascular, sympatho-adrenal and endocrine systems during physical exercise in man. Defer G; Guezennec CY; Fraitag B; Lhoste F Fundam Clin Pharmacol; 1987; 1(2):135-43. PubMed ID: 3315914 [TBL] [Abstract][Full Text] [Related]
10. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326 [TBL] [Abstract][Full Text] [Related]
13. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension. Katzman PL; Hulthén UL; Hökfelt B Acta Med Scand; 1988; 223(2):125-31. PubMed ID: 3279724 [TBL] [Abstract][Full Text] [Related]
14. Serotonergic mechanisms and blood pressure in sheep. Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029 [TBL] [Abstract][Full Text] [Related]